This article contains links to products or services from one or more of our advertisers or partners. We may receive a commission when you click or make a purchase using our site. Learn more about how we make money.

How to buy Amneal Pharmaceuticals stock | $4.08

Own Amneal Pharmaceuticals stock in just a few minutes.

Posted

Fact checked

Amneal Pharmaceuticals, Inc is a drug manufacturers—specialty & generic business based in the US. Amneal Pharmaceuticals shares (AMRX) are listed on the NYSE and all prices are listed in US Dollars. Amneal Pharmaceuticals employs 5,500 staff and has a trailing 12-month revenue of around USD$1.7 billion.

How to buy shares in Amneal Pharmaceuticals

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Amneal Pharmaceuticals. Find the stock by name or ticker symbol: AMRX. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Amneal Pharmaceuticals reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$4.08, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Amneal Pharmaceuticals, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Amneal Pharmaceuticals. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Amneal Pharmaceuticals share price

Use our graph to track the performance of AMRX stocks over time.

Amneal Pharmaceuticals shares at a glance

Information last updated 2020-10-19.
Latest market close USD$4.08
52-week range USD$2.4 - USD$5.79
50-day moving average USD$4.1656
200-day moving average USD$4.2288
Wall St. target price USD$4.35
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.522

Buy Amneal Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Vanguard
$0
Stocks, Mutual funds, ETFs, Forex
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Amneal Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Amneal Pharmaceuticals price performance over time

Historical closes compared with the close of $4.08 from 2020-11-16

1 week (2020-11-25) 2.51%
1 month (2020-11-06) -1.21%
3 months (2020-09-04) 11.78%
6 months (2020-06-05) -17.58%
1 year (2019-12-05) 9.97%
2 years (2018-12-04) -76.91%
3 years (2017-12-05) -75.42%
5 years (2015-12-04) -90.77%

Is Amneal Pharmaceuticals under- or over-valued?

Valuing Amneal Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Amneal Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Amneal Pharmaceuticals's EBITDA

Amneal Pharmaceuticals's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$343 million.

The EBITDA is a measure of a Amneal Pharmaceuticals's overall financial performance and is widely used to measure a its profitability.

Amneal Pharmaceuticals financials

Revenue TTM USD$1.7 billion
Operating margin TTM 6.85%
Gross profit TTM USD$496.9 million
Return on assets TTM 1.79%
Return on equity TTM -58.39%
Profit margin -11.16%
Book value $2.075
Market capitalisation USD$759.8 million

TTM: trailing 12 months

Shorting Amneal Pharmaceuticals shares

There are currently 7.2 million Amneal Pharmaceuticals shares held short by investors – that's known as Amneal Pharmaceuticals's "short interest". This figure is 3.7% up from 6.9 million last month.

There are a few different ways that this level of interest in shorting Amneal Pharmaceuticals shares can be evaluated.

Amneal Pharmaceuticals's "short interest ratio" (SIR)

Amneal Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Amneal Pharmaceuticals shares currently shorted divided by the average quantity of Amneal Pharmaceuticals shares traded daily (recently around 959895.44846051). Amneal Pharmaceuticals's SIR currently stands at 7.47. In other words for every 100,000 Amneal Pharmaceuticals shares traded daily on the market, roughly 7470 shares are currently held short.

However Amneal Pharmaceuticals's short interest can also be evaluated against the total number of Amneal Pharmaceuticals shares, or, against the total number of tradable Amneal Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Amneal Pharmaceuticals's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Amneal Pharmaceuticals shares in existence, roughly 50 shares are currently held short) or 0.0864% of the tradable shares (for every 100,000 tradable Amneal Pharmaceuticals shares, roughly 86 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Amneal Pharmaceuticals.

Find out more about how you can short Amneal Pharmaceuticals stock.

Amneal Pharmaceuticals share dividends

We're not expecting Amneal Pharmaceuticals to pay a dividend over the next 12 months.

Amneal Pharmaceuticals share price volatility

Over the last 12 months, Amneal Pharmaceuticals's shares have ranged in value from as little as $2.4 up to $5.79. A popular way to gauge a stock's volatility is its "beta".

AMRX.US volatility(beta: 1.49)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Amneal Pharmaceuticals's is 1.4867. This would suggest that Amneal Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Amneal Pharmaceuticals overview

Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates in two segments, Generics and Specialty. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, manufacture, and sale of branded pharmaceutical products primarily for central nervous system disorders, endocrinology, parasitic infections, and other therapeutic areas. It also offers licensed and owned, niche, and mature branded products, as well as Rytary for the treatment of Parkinsons Disease; Zomig for the treatment of migraine headaches; Emverm a chewable tablets for the treatment of pinworm, whipworm, common roundworm, common hookworm, and American hookworm in single or mixed infections; and Unithroid for the treatment of hypothyroidism. The company sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies. It has operations in the United States, India, Ireland, and internationally. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is based in Bridgewater, New Jersey.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site